Computationally Guided Approach to Produce Ratiometric Probes Operating in the Red to Near-infrared Region to Accurately Determine pH Levels within Organelles

计算引导方法生产在红色至近红外区域运行的比率探针,以准确确定细胞器内的 pH 水平

基本信息

  • 批准号:
    10796036
  • 负责人:
  • 金额:
    $ 46.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-18 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Abstract Employing a computationally guided approach, this project will develop ratiometric fluorescent probes operating in the red to the near-infrared region to accurately determine extracellular and intracellular pH changes across cell membranes and in different organelles, such as lysosomes, mitochondria, the endoplasmic reticulum, the Golgi apparatus, and to monitor mitochondrial delivery to the lysosomes during mitophagy caused by nutrient starvation, hypoxia, and drug treatment. Spectrochemical attributes of probes will be determined before synthesis in order to judge applicability in the desired spectral range. Probes will consist of near-infrared fluorophores linked into near-infrared rhodol dyes to achieve ratiometric responses to pH changes based on pH modulation resulting in π-conjugation changes of the probes. Red to near-infrared fluorophores will include BODIPY dyes, traditional near-infrared xanthene dyes, and their derivatives, where the central oxygen atom of xanthene cores will be replaced by other elements such as Si, S, and N. Spirolactone and spirolactam molecular switches that can be tuned to appropriate pKa values matching the different organelles under study will be used. Specific targeting to different organelles and cell membranes will be achieved by introducing lysosome-specific morpholine, mitochondria-specific triphenylphosphonium, Golgi apparatus-specific benzenesulfonamide, endoplasmic reticulum-specific p-toluene sulfonamide, or cell membrane-specific amphilphilic zwitterion residues through oligo(ethylene glycol) spacers to the fluorescent probes. The ratiometric red to near-infrared fluorescent probes based on spirolactam switches will have pKa values from 4.5 to 6.2 and will only show fluorescence of near-infrared fluorophores under neutral and basic pH conditions since rhodol moieties have closed spirolactam ring structures under the slightly basic conditions within mitochondria. A lysosomal acidic environment will trigger the opening of the spirolactam switches on the rhodol moieties, significantly enhancing π-conjugation between the fluorophore and rhodol moieties, resulting in ratiometric fluorescence responses to pH changes. These processes will also be delineated via theoretical calculations before syntheses are conducted. The probes will have the combined advantages of near- infrared imaging (including deep tissue penetration, minimum cell damage, lack of interference from biological autofluorescence), and ratiometric imaging with a self-calibration feature to overcome systematic errors of intensity-only based fluorescent probes. In addition, the probes will possess good water solubility, high stability, excellent cell permeability, good biocompatibility, excellent intracellular retention, high selectivity, and sensitivity, as well as fast and reversible responses to pH changes. Seven undergraduate students will assist in conducting these experiments for each year of the proposal which will allow them to learn valuable synthetic and characterization research skills in this area. Undergraduate students will also conduct theoretical calculations, using the program Gaussian, to determine the absorptive properties of the probes.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rudy Lin Luck其他文献

Rudy Lin Luck的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
  • 批准号:
    30840003
  • 批准年份:
    2008
  • 资助金额:
    12.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
  • 批准号:
    478914
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
    Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
  • 批准号:
    23K14913
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
  • 批准号:
    23K15035
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
  • 批准号:
    10442874
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
  • 批准号:
    10657069
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
  • 批准号:
    23K08326
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
  • 批准号:
    23K14614
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
  • 批准号:
    23K15075
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
  • 批准号:
    23H02698
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
  • 批准号:
    10743611
  • 财政年份:
    2023
  • 资助金额:
    $ 46.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了